| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 10/28/2004 | WO2004047925A3 Therapeutic oxidation catalysts |
| 10/28/2004 | WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 10/28/2004 | WO2003030833A3 Angiopoietin-2 specific binding agents |
| 10/28/2004 | US20040215019 Substituted isoindoles and the e use thereof |
| 10/28/2004 | US20040215018 use as selective estrogen receptor modulators, and use in inhibiting bone loss, cardiovascular disease, and breast and uterine carcinoma |
| 10/28/2004 | US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders |
| 10/28/2004 | US20040214901 derivatives which inhibit pancreatic lipase and therefore can be used in combating or preventing obesity and hyperlipaemias |
| 10/28/2004 | US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis |
| 10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 10/28/2004 | US20040214864 Novel compounds |
| 10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
| 10/28/2004 | US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens |
| 10/28/2004 | US20040214816 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | US20040214793 In aitu applying to bone joints |
| 10/28/2004 | US20040214761 induction of apoptosis in tumor cells by administering monoclonal antibodies |
| 10/28/2004 | US20040214759 Compositions and methods of use for a fibroblast growth factor |
| 10/28/2004 | US20040214349 Molecular marker |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis |
| 10/28/2004 | US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3 |
| 10/28/2004 | CA2522522A1 Quinazoline compounds |
| 10/28/2004 | CA2522195A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2521991A1 Arthritis preventing or treating agent |
| 10/28/2004 | CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 10/28/2004 | CA2520785A1 Substituted 7-aza-quinazoline compounds |
| 10/27/2004 | EP1471143A1 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 10/27/2004 | EP1471065A1 Novel 1,2,4-triazole compound |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1470826A1 Decoy-containing pharmaceutical compositions and method of using the same |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 10/27/2004 | EP1470150A2 Corticosteroids nitrate derivatives |
| 10/27/2004 | EP1470138A1 Mmp inhibitors |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470124A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES |
| 10/27/2004 | EP1470122A1 Rho-kinase inhibitors |
| 10/27/2004 | EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
| 10/27/2004 | EP1470109A1 Metabolites of (3- [(4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl -phenoxy)-acetic acid |
| 10/27/2004 | EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 10/27/2004 | EP1469878A2 Fgfr agonists |
| 10/27/2004 | EP1469861A1 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen |
| 10/27/2004 | EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |
| 10/27/2004 | EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators |
| 10/27/2004 | EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 10/27/2004 | EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands |
| 10/27/2004 | EP1469835A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 10/27/2004 | EP1416944A4 Composition for treatment of articular cartilage damage |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP1244457B1 Use of modulators of annexin for the manufacture of a medicament for the treatment and/or prevention of arthritis and arthritic diseases |
| 10/27/2004 | EP1240102B1 Hydroxyl apatite material containing tricalcium phosphate, having a microporous structure |
| 10/27/2004 | EP1237578A4 Micro-cluster liquids and methods of making and using them |
| 10/27/2004 | EP1027027A4 Therapeutic method |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | CN1541275A Glycoprotein and process for producing same |
| 10/27/2004 | CN1541262A Hops extracts, method for prodn. and use |
| 10/27/2004 | CN1541224A Antagonistic anti-hTNFSF13b Human antibodies |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541107A Growth factor complex |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1539484A Vulnerary for treating fracture |
| 10/27/2004 | CN1539479A Drug for curing disease of proplapse of lumbar intervertebral disc |
| 10/27/2004 | CN1539476A Plaster for treating bone disease |
| 10/27/2004 | CN1539472A Plaster for treating prolapse of intervertebral disc |
| 10/27/2004 | CN1539470A External Chinese patent medicines for curing periarthritis humeroscapularis and myotenositis |
| 10/27/2004 | CN1539457A Medicinal liquor for curing rheumatism |
| 10/27/2004 | CN1539448A Drug for curing reheumatoid arthritis and atrophic artjritis |
| 10/27/2004 | CN1539437A External use tincture for curing hyperosteogeny as well as arthralgia and myalgia |
| 10/27/2004 | CN1539428A New medical usage of effective part of Chinese drug compound 'Qing'e' prescription and preparation method |
| 10/27/2004 | CN1539427A Icariin in application of preparing medication for treating and preventing osteoporosis |
| 10/27/2004 | CN1172929C Substituted indoles for modulating NFKB activity |
| 10/27/2004 | CN1172724C Bone grafting matrix |
| 10/27/2004 | CN1172697C Chinese adhesive plaster for curing rheumatism and hyperosteogeny |
| 10/27/2004 | CN1172690C Chinese medicine powder for treating tetanic rachitis |
| 10/27/2004 | CN1172671C Medicial composition for oral administration |
| 10/27/2004 | CN1172658C Protein formulations |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
| 10/26/2004 | US6809175 Cadherin derived growth factor and its use |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809095 Novel antitobesity and hypocholesterolemic compounds lower total cholesterol; increase high density lipoprotein (hdl) and decrease low denstiy lipoprotein |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 10/21/2004 | WO2004089962A2 New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 10/21/2004 | WO2004089913A1 Aminopyrimidine derivatives and their medical use |
| 10/21/2004 | WO2004089467A1 Electromagnetic stimulation in patients with osteoporosis |
| 10/21/2004 | WO2004089405A1 Therapeutic composition for autoimmune conditions |
| 10/21/2004 | WO2004089399A1 Novel uses of rfrp and ot7t022 |
| 10/21/2004 | WO2004089389A1 Pharmaceutical composition for prevention and treatment of osteoporosis and its preparation |
| 10/21/2004 | WO2004089388A1 The ready-prepared chinese medicine for treatment of hair loss and process of manufacturing thereof |